These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24449987)

  • 21. Dosage adjustment of anti-tumor necrosis factor-α inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice.
    Paccou J; Baclé-Boutry MA; Solau-Gervais E; Bele-Philippe P; Flipo RM
    J Rheumatol; 2012 Jul; 39(7):1418-23. PubMed ID: 22707611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
    Appel H; Janssen L; Listing J; Heydrich R; Rudwaleit M; Sieper J
    Arthritis Res Ther; 2008; 10(5):R125. PubMed ID: 18945353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of adalimumab after drug withdrawal and retreatment in patients with active non-radiographically evident axial spondyloarthritis who experience a flare.
    Haibel H; Heldmann F; Braun J; Listing J; Kupper H; Sieper J
    Arthritis Rheum; 2013 Aug; 65(8):2211-3. PubMed ID: 23686466
    [No Abstract]   [Full Text] [Related]  

  • 25. Sacroiliitis in patients with ankylosing spondylitis: association of MR findings with disease activity.
    Jee WH; McCauley TR; Lee SH; Kim SH; Im SA; Ha KY
    Magn Reson Imaging; 2004 Feb; 22(2):245-50. PubMed ID: 15010117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
    Malaviya AN; Sawhney S; Kapoor S; Garg S
    J Assoc Physicians India; 2010 Nov; 58():709-11. PubMed ID: 21510471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis?
    Weber U; Zubler V; Zhao Z; Lambert RG; Chan SM; Pedersen SJ; Østergaard M; Rufibach K; Maksymowych WP
    Ann Rheum Dis; 2015 Jun; 74(6):985-92. PubMed ID: 24451240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
    Maksymowych WP; Lambert R; Jhangri GS; Leclercq S; Chiu P; Wong B; Aaron S; Russell AS
    J Rheumatol; 2001 Jan; 28(1):144-55. PubMed ID: 11196517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.
    Brandt J; Haibel H; Cornely D; Golder W; Gonzalez J; Reddig J; Thriene W; Sieper J; Braun J
    Arthritis Rheum; 2000 Jun; 43(6):1346-52. PubMed ID: 10857793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ankylosing spondyloarthritis and psoriasis].
    Badokin VV
    Ter Arkh; 1982; 54(6):103-6. PubMed ID: 7112407
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
    Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of secukinumab in the treatment of ankylosing spondylitis.
    Shah R; Perry L; Deodhar A
    Immunotherapy; 2015; 7(12):1241-7. PubMed ID: 26595091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermography of the spine and sacro-iliac joints in spondylitis.
    Agarwal A; Lloyd KN; Dovey P
    Rheumatol Phys Med; 1970 Aug; 10(7):349-55. PubMed ID: 5458846
    [No Abstract]   [Full Text] [Related]  

  • 35. Magnetic resonance imaging in ankylosing spondylitis.
    Zochling J; Baraliakos X; Hermann KG; Braun J
    Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.
    Huang F; Gu J; Zhu P; Bao C; Xu J; Xu H; Wu H; Wang G; Shi Q; Andhivarothai N; Anderson J; Pangan AL
    Ann Rheum Dis; 2014 Mar; 73(3):587-94. PubMed ID: 23475983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
    Callhoff J; Sieper J; Weiß A; Zink A; Listing J
    Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging in axial spondyloarthritis: diagnostic problems and pitfalls.
    Baraliakos X; Hermann KG; Braun J
    Rheum Dis Clin North Am; 2012 Aug; 38(3):513-22. PubMed ID: 23083752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-TNFα therapy in ankylosing spondylitis: symptom control and structural damage modification].
    Andreu JL; Otón T; Sanz J
    Reumatol Clin; 2011; 7(1):51-5. PubMed ID: 21794779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.
    Maksymowych WP; Rahman P; Shojania K; Olszynski WP; Thomson GT; Ballal S; Wong RL; Inman RD;
    J Rheumatol; 2008 Oct; 35(10):2030-7. PubMed ID: 18785308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.